Carbapenemase-Producing Organisms: A Global Scourge

Queenan, 2007, Carbapenemases: the versatile beta-lactamases, Clin Microbiol Rev, 20, 440, 10.1128/CMR.00001-07

Kim, 2006, Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase, Mol Microbiol, 60, 907, 10.1111/j.1365-2958.2006.05146.x

Naas, 2013, Complete sequence of two KPC-harbouring plasmids from Pseudomonas aeruginosa, J Antimicrob Chemother, 68, 1757, 10.1093/jac/dkt094

Munoz-Price, 2013, Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases, Lancet Infect Dis, 13, 785, 10.1016/S1473-3099(13)70190-7

Palzkill, 2013, Metallo-β-lactamase structure and function, Ann N Y Acad Sci, 1277, 91, 10.1111/j.1749-6632.2012.06796.x

Walsh, 2005, Metallo-beta-lactamases: the quiet before the storm, Clin Microbiol Rev, 18, 306, 10.1128/CMR.18.2.306-325.2005

Edelstein, 2013, Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study, Lancet Infect Dis, 13, 867, 10.1016/S1473-3099(13)70168-3

Poirel, 2012, OXA-48-like carbapenemases: the phantom menace, J Antimicrob Chemother, 67, 1597, 10.1093/jac/dks121

Potron, 2016, Characterisation of OXA-244, a chromosomally-encoded OXA-48-like β-lactamase from Escherichia coli, Int J Antimicrob Agents, 47, 102, 10.1016/j.ijantimicag.2015.10.015

Nordmann, 2014, The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide, Clin Microbiol Infect, 20, 821, 10.1111/1469-0691.12719

Potron, 2014, Derepressed transfer properties leading to the efficient spread of the plasmid encoding carbapenemase OXA-48, Antimicrob Agents Chemother, 58, 467, 10.1128/AAC.01344-13

Potron, 2015, Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology, Int J Antimicrob Agents, 45, 568, 10.1016/j.ijantimicag.2015.03.001

Girlich, 2012, Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae, J Clin Microbiol, 50, 477, 10.1128/JCM.05247-11

Vasoo, 2013, Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing gram-negative bacilli, J Clin Microbiol, 51, 3097, 10.1128/JCM.00965-13

Carvalhaes, 2010, Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results, J Antimicrob Chemother, 65, 249, 10.1093/jac/dkp431

van der Zwaluw, 2015, The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods, PLoS One, 10, e0123690, 10.1371/journal.pone.0123690

Tijet, 2016, Detection of carbapenemase activity in Enterobacteriaceae: comparison of the carbapenem inactivation method versus the Carba NP test, J Antimicrob Chemother, 71, 274, 10.1093/jac/dkv283

Pierce, 2017, Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae, J Clin Microbiol, 55, 2321, 10.1128/JCM.00193-17

Clinical and Laboratory Standards Institute (CLSI), 2017, Performance standards for antimicrobial susceptibility testing, 27th ed

Nordmann, 2012, Rapid detection of carbapenemase-producing Enterobacteriaceae, Emerg Infect Dis, 18, 1503, 10.3201/eid1809.120355

Hrabák, 2012, Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry, J Clin Microbiol, 50, 2441, 10.1128/JCM.01002-12

Papagiannitsis, 2015, Matrix-assisted laser desorption ionization-time of flight mass spectrometry meropenem hydrolysis assay with NH4HCO3, a reliable tool for direct detection of carbapenemase activity, J Clin Microbiol, 53, 1731, 10.1128/JCM.03094-14

Dortet, 2014, Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures, Clin Microbiol Infect, 20, 340, 10.1111/1469-0691.12318

Migliavacca, 2002, Simple microdilution test for detection of metallo-beta-lactamase production in Pseudomonas aeruginosa, J Clin Microbiol, 40, 4388, 10.1128/JCM.40.11.4388-4390.2002

Tsakris, 2010, A simple phenotypic method for the differentiation of metallo-beta-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates, J Antimicrob Chemother, 65, 1664, 10.1093/jac/dkq210

Miriagou, 2013, Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers, Clin Microbiol Infect, 19, E412, 10.1111/1469-0691.12238

Girlich, 2013, Evaluation of Etest strips for detection of KPC and metallo-carbapenemases in Enterobacteriaceae, Diagn Microbiol Infect Dis, 77, 200, 10.1016/j.diagmicrobio.2013.08.002

van Dijk, 2014, A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin, Clin Microbiol Infect, 20, 345, 10.1111/1469-0691.12322

Cuzon, 2012, Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM), J Antimicrob Chemother, 67, 1865, 10.1093/jac/dks156

Kaase, 2012, Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR, J Clin Microbiol, 50, 3115, 10.1128/JCM.00991-12

Dodémont, 2014, Performance of the Verigene gram-negative blood culture assay for rapid detection of bacteria and resistance determinants, J Clin Microbiol, 52, 3085, 10.1128/JCM.01099-14

Salimnia, 2016, Evaluation of the FilmArray blood culture identification panel: results of a multicenter controlled trial, J Clin Microbiol, 54, 687, 10.1128/JCM.01679-15

Tato, 2016, Multisite evaluation of Cepheid Xpert Carba-R assay for detection of carbapenemase-producing organisms in rectal swabs, J Clin Microbiol, 54, 1814, 10.1128/JCM.00341-16

Snitkin, 2012, Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing, Sci Transl Med, 4, 148ra116, 10.1126/scitranslmed.3004129

Mathers, 2015, Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae at a single institution: insights into endemicity from whole-genome sequencing, Antimicrob Agents Chemother, 59, 1656, 10.1128/AAC.04292-14

Pecora, 2015, Genomically informed surveillance for carbapenem-resistant Enterobacteriaceae in a health care system, MBio, 6, e01030, 10.1128/mBio.01030-15

Köser, 2012, Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak, N Engl J Med, 366, 2267, 10.1056/NEJMoa1109910

Harris, 2013, Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study, Lancet Infect Dis, 13, 130, 10.1016/S1473-3099(12)70268-2

Köser, 2012, Routine use of microbial whole genome sequencing in diagnostic and public health microbiology, PLoS Pathog, 8, e1002824, 10.1371/journal.ppat.1002824

Wright, 2017, Transcriptome remodeling of Acinetobacter baumannii during infection and treatment, MBio, 8, 10.1128/mBio.02193-16

Wright, 2016, Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment, Genome Med, 8, 26, 10.1186/s13073-016-0279-y

Conlan, 2014, Single-molecule sequencing to track plasmid diversity of hospital-associated carbapenemase-producing Enterobacteriaceae, Sci Transl Med, 6, 254ra126, 10.1126/scitranslmed.3009845

Poirel, 2016, In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae, J Antimicrob Chemother, 71, 156, 10.1093/jac/dkv294

Qureshi, 2012, Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens, Antimicrob Agents Chemother, 56, 2108, 10.1128/AAC.06268-11

Tumbarello, 2012, Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy, Clin Infect Dis, 55, 943, 10.1093/cid/cis588

Tzouvelekis, 2014, Treating infections caused by carbapenemase-producing Enterobacteriaceae, Clin Microbiol Infect, 20, 862, 10.1111/1469-0691.12697

Falagas, 2014, Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence, Antimicrob Agents Chemother, 58, 654, 10.1128/AAC.01222-13

van Duin, 2017, Colistin vs. ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae [manuscript published online ahead of print 4 September 2017], Clin Infect Dis

Perez, 2016, Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy, Expert Opin Pharmacother, 17, 761, 10.1517/14656566.2016.1145658

Shields, 2016, Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections, Clin Infect Dis, 63, 1615, 10.1093/cid/ciw636

Spellberg, 2016, Editorial commentary: ceftazidime-avibactam and carbapenem-resistant Enterobacteriaceae: “We’re gonna need a bigger boat.”, Clin Infect Dis, 63, 1619, 10.1093/cid/ciw639

Papp-Wallace, 2016, New β-lactamase inhibitors in the clinic, Infect Dis Clin North Am, 30, 441, 10.1016/j.idc.2016.02.007

Drusano, 2016, From lead optimization to NDA approval for a new antimicrobial: use of pre-clinical effect models and pharmacokinetic/pharmacodynamic mathematical modeling, Bioorg Med Chem, 24, 6401, 10.1016/j.bmc.2016.08.034

Carpentier, 2010, Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study, Neuro Oncol, 12, 401, 10.1093/neuonc/nop047

Mattoes, 2004, Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenem, Clin Ther, 26, 1187, 10.1016/S0149-2918(04)80001-8

Schwaber, 2011, Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally-implemented intervention, Clin Infect Dis, 52, 1, 10.1093/cid/cir025

World Health Organization, 2008, International health regulations (2005)

Wernli, 2011, A call for action: the application of the International Health Regulations to the global threat of antimicrobial resistance, PLoS Med, 8, e1001022, 10.1371/journal.pmed.1001022

Walsh, 2011, Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study, Lancet Infect Dis, 11, 355, 10.1016/S1473-3099(11)70059-7

Liu, 2016, Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study, Lancet Infect Dis, 16, 161, 10.1016/S1473-3099(15)00424-7

Kamradt-Scott, 2011, A public health emergency of international concern? Response to a proposal to apply the International Health regulations to antimicrobial resistance, PLoS Med, 8, e1001021, 10.1371/journal.pmed.1001021